KalVista Pharmaceuticals, Inc. (KALV) Stock price, Description, News & Info
#Thinksabio latest news KalVista Pharmaceuticals Presents New Data Highlighting Patient Satisfaction with EKTERLY® (sebetralstat) and...
#Thinksabio latest news KalVista Pharmaceuticals Presents New Data Highlighting Patient Satisfaction with EKTERLY® (sebetralstat) and...
#Thinksabio latest news Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy...
#Thinksabio latest news Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in...
#Thinksabio latest news BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric...
#Thinksabio latest news Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2...
#Thinksabio latest news Celldex Presents Additional Positive Data Demonstrating Barzolvolimab’s Ability to Drive Rapid, Profound...
#Thinksabio latest news Amaze Expands Into the Metaverse Through Strategic Partnership with DubitAmaze and Dubit...
#Thinksabio latest news Nunes Issues Statement on Secret Subpoena of Trump Media Bank Records
#Thinksabio latest news Worksport Announces Official Launch Date for SOLIS and COR Clean Energy Products
#Thinksabio latest news SEGG Media Charts a Bold Course into Web3 with $300M Digital Asset...